The dysfunctional endothelium in CKD and in cardiovascular disease: Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda

Danilo Fliser, Andrzej Wiecek, Gultekin Suleymanlar, Alberto Ortiz, Ziad Massy, Bengt Lindholm, Alberto Martinez-Castelao, Rajiv Agarwal, Kitty J. Jager, Friedo W. Dekker, Peter J. Blankestijn, David Goldsmith, Adrian Covic, Gerard London, Carmine Zoccali

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Endothelial dysfunction resulting in disintegration of vascular structure and function is a key element in the progression of chronic kidney disease (CKD). Many risk factors-traditional and non-traditional-are thought to have a role in the progression and development of cardiovascular disease (CVD) in patients with CKD. However, many risk factors await definitive confirmation of their clinical relevance obtained from intervention trials. Moreover, the investigation of the relative contribution of these factors to the twin-risk problem of CVD and progression in patients with CKD is one of the most important future challenges for nephrologists.

Original languageEnglish (US)
Pages (from-to)6-9
Number of pages4
JournalKidney International Supplements
Volume1
Issue number1
DOIs
StatePublished - Jun 1 2011

Fingerprint

Kidney Diseases
Chronic Renal Insufficiency
Endothelium
Cardiovascular Diseases
Research
Blood Vessels
Disease Progression

Keywords

  • biomarkers
  • cardiovascular disease
  • chronic kidney disease
  • endothelium

ASJC Scopus subject areas

  • Nephrology

Cite this

The dysfunctional endothelium in CKD and in cardiovascular disease : Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. / Fliser, Danilo; Wiecek, Andrzej; Suleymanlar, Gultekin; Ortiz, Alberto; Massy, Ziad; Lindholm, Bengt; Martinez-Castelao, Alberto; Agarwal, Rajiv; Jager, Kitty J.; Dekker, Friedo W.; Blankestijn, Peter J.; Goldsmith, David; Covic, Adrian; London, Gerard; Zoccali, Carmine.

In: Kidney International Supplements, Vol. 1, No. 1, 01.06.2011, p. 6-9.

Research output: Contribution to journalReview article

Fliser, D, Wiecek, A, Suleymanlar, G, Ortiz, A, Massy, Z, Lindholm, B, Martinez-Castelao, A, Agarwal, R, Jager, KJ, Dekker, FW, Blankestijn, PJ, Goldsmith, D, Covic, A, London, G & Zoccali, C 2011, 'The dysfunctional endothelium in CKD and in cardiovascular disease: Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda', Kidney International Supplements, vol. 1, no. 1, pp. 6-9. https://doi.org/10.1038/kisup.2011.6
Fliser, Danilo ; Wiecek, Andrzej ; Suleymanlar, Gultekin ; Ortiz, Alberto ; Massy, Ziad ; Lindholm, Bengt ; Martinez-Castelao, Alberto ; Agarwal, Rajiv ; Jager, Kitty J. ; Dekker, Friedo W. ; Blankestijn, Peter J. ; Goldsmith, David ; Covic, Adrian ; London, Gerard ; Zoccali, Carmine. / The dysfunctional endothelium in CKD and in cardiovascular disease : Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. In: Kidney International Supplements. 2011 ; Vol. 1, No. 1. pp. 6-9.
@article{d209926e1a9f409da4eb5a16db833f44,
title = "The dysfunctional endothelium in CKD and in cardiovascular disease: Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda",
abstract = "Endothelial dysfunction resulting in disintegration of vascular structure and function is a key element in the progression of chronic kidney disease (CKD). Many risk factors-traditional and non-traditional-are thought to have a role in the progression and development of cardiovascular disease (CVD) in patients with CKD. However, many risk factors await definitive confirmation of their clinical relevance obtained from intervention trials. Moreover, the investigation of the relative contribution of these factors to the twin-risk problem of CVD and progression in patients with CKD is one of the most important future challenges for nephrologists.",
keywords = "biomarkers, cardiovascular disease, chronic kidney disease, endothelium",
author = "Danilo Fliser and Andrzej Wiecek and Gultekin Suleymanlar and Alberto Ortiz and Ziad Massy and Bengt Lindholm and Alberto Martinez-Castelao and Rajiv Agarwal and Jager, {Kitty J.} and Dekker, {Friedo W.} and Blankestijn, {Peter J.} and David Goldsmith and Adrian Covic and Gerard London and Carmine Zoccali",
year = "2011",
month = "6",
day = "1",
doi = "10.1038/kisup.2011.6",
language = "English (US)",
volume = "1",
pages = "6--9",
journal = "Kidney International Supplements",
issn = "2157-1724",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The dysfunctional endothelium in CKD and in cardiovascular disease

T2 - Mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda

AU - Fliser, Danilo

AU - Wiecek, Andrzej

AU - Suleymanlar, Gultekin

AU - Ortiz, Alberto

AU - Massy, Ziad

AU - Lindholm, Bengt

AU - Martinez-Castelao, Alberto

AU - Agarwal, Rajiv

AU - Jager, Kitty J.

AU - Dekker, Friedo W.

AU - Blankestijn, Peter J.

AU - Goldsmith, David

AU - Covic, Adrian

AU - London, Gerard

AU - Zoccali, Carmine

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Endothelial dysfunction resulting in disintegration of vascular structure and function is a key element in the progression of chronic kidney disease (CKD). Many risk factors-traditional and non-traditional-are thought to have a role in the progression and development of cardiovascular disease (CVD) in patients with CKD. However, many risk factors await definitive confirmation of their clinical relevance obtained from intervention trials. Moreover, the investigation of the relative contribution of these factors to the twin-risk problem of CVD and progression in patients with CKD is one of the most important future challenges for nephrologists.

AB - Endothelial dysfunction resulting in disintegration of vascular structure and function is a key element in the progression of chronic kidney disease (CKD). Many risk factors-traditional and non-traditional-are thought to have a role in the progression and development of cardiovascular disease (CVD) in patients with CKD. However, many risk factors await definitive confirmation of their clinical relevance obtained from intervention trials. Moreover, the investigation of the relative contribution of these factors to the twin-risk problem of CVD and progression in patients with CKD is one of the most important future challenges for nephrologists.

KW - biomarkers

KW - cardiovascular disease

KW - chronic kidney disease

KW - endothelium

UR - http://www.scopus.com/inward/record.url?scp=84861510151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861510151&partnerID=8YFLogxK

U2 - 10.1038/kisup.2011.6

DO - 10.1038/kisup.2011.6

M3 - Review article

AN - SCOPUS:84861510151

VL - 1

SP - 6

EP - 9

JO - Kidney International Supplements

JF - Kidney International Supplements

SN - 2157-1724

IS - 1

ER -